Abeliaside, a new phenolic glucoside from Abelia triflora

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A new phenolic glucoside, abeliaside, along with four known compounds, 5,6,7,4′-tetrahydroxy flavones, caffeic acid, 4-O-caffeoylquinic acid and caffeic acid glucoside, was isolated from the leaves of Abelia triflora R. Br. (Caprifoliaceae). The structure of the new compound was elucidated by different spectroscopic techniques. Compounds 1-5 were assayed for their anticancer activities against two cancerous human cell lines, MCF-7 and PC-3 cells, and normal Vero cell line using the crystal violet staining method. From the results it could be seen that caffeic acid possessed the highest anticancer effect against MCF-7 (IC50: 17 g/mL) and PC-3 (IC50: 20.1 g/mL) compared to vinblastine sulphate as reference drug (IC50: 4.6, 2.8 g/mL). The other compounds showed weak anticancer activity on both cell lines.

Cite

CITATION STYLE

APA

Al-Taweel, A. M., Perveen, S., Fawzy, G. A., Khan, A., Mehmood, R., & Malik, A. (2015). Abeliaside, a new phenolic glucoside from Abelia triflora. Natural Product Research, 29(21), 1978–1984. https://doi.org/10.1080/14786419.2015.1016941

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free